Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SDHB Gene Mutation”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07434843
What this trial is testing

PH 2 Pemigatinib in SDH-deficient GIST

Who this might be right for
SDH Gene MutationGastrointestinal Stromal Tumor
Dana-Farber Cancer Institute 24
Testing effectiveness (Phase 2)Study completedNCT01967576
What this trial is testing

Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Metastatic, Recurrent or Primary Unresectable Pheochromocytoma/Paraganglioma

Who this might be right for
PheochromocytomaParaganglioma
National Cancer Institute (NCI) 14
Not applicableLooking for participantsNCT03749980
What this trial is testing

MyVHL: Patient Natural History Study

Who this might be right for
Von Hippel-Lindau DiseaseHereditary Leiomyomatosis and Renal Cell CancerBirt-Hogg-Dube Syndrome+1 more
Joshua Mann, MPH 10,000
Not applicableUnknownNCT04481152
What this trial is testing

Impact of Environmental Exposures on Tumor Risk in Subjects at Risk of Hereditary SDHx Paraganglioma

Who this might be right for
Genetic PredispositionSDH Gene MutationEnvironmental Exposure
Assistance Publique - Hôpitaux de Paris 100
Not applicableNot Yet RecruitingNCT06408402
What this trial is testing

Impact of Environmental Exposures on Tumor Risk in SDHx-mutation Carriers

Who this might be right for
SDH-Related Familial ParagangliomaSDHx-Related SyndromesSDH Gene Mutation+1 more
Assistance Publique - Hôpitaux de Paris 1,300
Testing effectiveness (Phase 2)Active Not RecruitingNCT06087263
What this trial is testing

Phase 2 Study to Evaluate the Efficacy of Regorafenib in Specific GIST Mutation Subsets (KIT Exon 17, 18, or 14 Mutation and SDHB Deficient GIST) in the Post-imatinib Second-line Setting.

Who this might be right for
Gastrointestinal Stromal Tumors
M.D. Anderson Cancer Center 3